SAHPRA approves the use of Pfizer vaccine for children from the age of 12#ProgressiveTalk

The South African Product Health Regulatory Authority has approved the use of the Pfizer vaccine for children from the age of 12. SAHPRA CEO Boitumelo Semete said the regulator's decision came after a review of updated safety and efficacy information submitted in March this year. Nghamula Chauke spoke to Acting Deputy Vice-Chancellor Research & Innovation University of KwaZulu-Natal’s Professor Mosa Moshabela for a reaction.